Farewell to Chris Richardson

Chris Richardson joined the lab as a Postdoctoral Fellow in July 2014 and made huge advances in human gene editing. He developed new ways to improve NHEJ and HDR, plus discovered out that genome editing in human cells works via the Fanconi Anemia Pathway. Three major first author papers in three years – not bad! Chris will be joining Spotlight Therapeutics as a Group Leader, and may have some additional career news to share soon. We wish you success in all your future endeavors!

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

July 9, 2024

CCAR1 PROMOTES DNA REPAIR VIA ALTERNATIVE SPLICING – PUBLISHED IN MOLECULAR CELL

Cells constantly experience DNA damage throughout their lifespan due to a variety of endogenous and exogenous factors. Among the different types of DNA damage,...

July 1, 2024

Latsis Symposium on Genome and Transcriptome Engineering 2024

The Latsis Symposium on Genome and Transcriptome Engineering, held on June 13-14, 2024 in Zurich, was a remarkable event! This dynamic two-day gathering ...

July 1, 2024

D-BIOL Symposium 2024

From June 10-12, 2024, the Corn Lab members attended the 14th D-BIOL Symposium in Davos. This exciting biannual internal ETHZ event brought together nearly...

News Archive

Tweets